Gilead Sciences reported $2.75B in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Biogen BIIB:US $ 814.2M 255M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Bristol Myers Squibb BMY:US $ 5289M 67M
Coherus Biosciences CHRS:US $ -38.53M 11.22M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Johnson & Johnson JNJ:US $ 8058M 282M
Moderna Inc MRNA:US 3.55B 489M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Puma Biotechnology PBYI:US $ -20.14M 15.04M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
United Therapeutics UTHR:US $ 204.4M 12.1M